Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic
Plus’ CSF-01 cancer cell enumeration test is a sensitive and specific diagnostic test for the presence of adenocarcinoma and melanoma...
Pharmaceutical
One World Products, Inc. Secures Exclusive Rights With Procepack for State-of-the-Art PreRoll-Er Equipment in Colombia
LAS VEGAS, NV, March 25, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- One World Products, Inc. ("OWP") (OTCQB: OWPC), a...
Bluejay Announces Receipt of PRIME Designation from European Medicines Agency (EMA) for BJT-778 for the Treatment of Chronic Hepatitis Delta Virus Infection
Currently Enrolling Phase 2 Study of BJT-778 in HDV; Interim Data Expected second half of 2024SAN MATEO, Calif., March 25,...
Olink reports fourth quarter and full year 2023 financial results
UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial...
Olink publishes 2023 annual report
UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual...
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
ZÜRICH, SWITZERLAND / ACCESSWIRE / March 22, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
GE HealthCare Announces Cash Dividend for First Quarter of 2024
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per...
GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024
Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases and health conditions Scientific studies...
Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th
Poster presentation delivers pre-clinical results that demonstrate that its lead development product, Telomir-1, elongates telomere caps on human normal embryonic...
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 22, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced the receipt of U.S....
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
GENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a...
Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 22, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the...
United States Pharmacovigilance Market Research Report 2023: Demand Soars for Pharmacovigilance in Response to Escalating Adverse Drug Reactions – Forecasts to 2028 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "United States Pharmacovigilance Market, By Region, Competition Forecast and Opportunities, 2018-2028F" report has been added to ResearchAndMarkets.com's offering....
Viz.ai Names Michael Herring as Chief Financial Officer
Seasoned financial leader brings experience at leading companies in healthcare and software as a service (SaaS) to help company scale...
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business UnitVancouver, British Columbia and Rehovot, Israel--(Newsfile...
Superior Medical Waste Disposal Expands Service Area to Reach More Facilities in Michigan, Ohio, and Indiana
CANTON, MI / ACCESSWIRE / March 21, 2024 / Superior Medical Waste Disposal, one of the Midwest's leading medical waste...
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March...
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
Prioritizing and focusing on highest-value opportunities NC410 (ovarian and CRC) and LNCB74 (B7-H4 ADC)Based on early evidence of clinical activity...
LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments
-- Three Clinical Trials Currently Underway for Treating Ovarian, Lung and Sarcoma Cancers -- PASADENA, Calif., March 21, 2024 (GLOBE...
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
JUPITER, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology...